Key points
- Revenue of $6.5 million, reflecting strategic repositioning toward higher-margin, self-branded products
- Positive net operating cash flow of $0.322 million, demonstrating effective cost management and operational resilience
- Successful return and ongoing resale of Neurio® stock in the Australian market, with results exceeding expectations
Full summary
Jatcorp Limited (ASX: JAT), an Australian health and wellness consumer goods company, provided its quarterly activities and cash flow report for the quarter ending 31 March 2025 (Q3 FY25). The key highlights include:- Revenue of $6.5 million, reflecting a strategic repositioning toward higher-margin, self-branded products and the deliberate wind-down of the low-margin trading division.- Gross profit of $2.9 million, maintaining a strong margin profile despite reduced topline.- Positive net operating cash flow of $0.322 million, demonstrating effective cost management and operational resilience.- Strong brand momentum for Moroka® products, with consumer demand and brand equity continuing to grow in China.- Successful return and ongoing resale of Neurio® stock in the Australian market, with results exceeding expectations.- Strategic expansion of OEM manufacturing capabilities, with three new partners onboarded by ANMA.- Signed a Strategic Sales Incentive Agreement with Tier 1 retailer H&S International, expanding Jatcorp's distribution channels.- Appointed Dr Xinpeng (Sean) Li as Executive Director to support strategic expansion and R&D.Jatcorp remains positive heading into Q4 FY25, despite short-term uncertainties related to ongoing legal proceedings and a shifting geopolitical environment. The company expects continued growth of the Moroka® brand in China and plans to enter new international markets by leveraging its growing digital and physical sales channels.
Guidance
Jatcorp expects continued growth of the Moroka® brand in China and plans to enter new international markets by leveraging its growing digital and physical sales channels.